Cart
sales@molnova.com
Kudinoside D
CAS No. 173792-61-5
Kudinoside D( —— )
Catalog No. M23783 CAS No. 173792-61-5
Kudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 565 | In Stock |
|
| 10MG | 807 | In Stock |
|
| 25MG | 1215 | In Stock |
|
| 50MG | 1638 | In Stock |
|
| 100MG | 2214 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKudinoside D
-
NoteResearch use only, not for human use.
-
Brief DescriptionKudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.
-
DescriptionKudinoside D exerts anti-adipogenic effects through modulation of adipogenic transcription factors via AMPK signaling pathway.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorAMPK|LDL|PPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number173792-61-5
-
Formula Weight909.07
-
Molecular FormulaC47H72O17
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (110.00 mM)
-
SMILESC[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1O[C@H]([C@H]1O[C@@H]([C@@H]([C@H]2O)O)O[C@H](CO)[C@H]2O)[C@H](O[C@@H](CC2)C(C)(C)[C@H](CC[C@@]3(C)[C@]4(C)CC5)[C@@]2(C)[C@H]3C=CC4=C([C@@](C)(C(C)(CC2)O3)O)[C@@]25C3=O)OC[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Aldometanib
Aldometanib (LXY-05-029) is an orally active aldolase inhibitor that prevents FBP from binding to v-ATPase-associated aldolase and activates lysosomal AMPK, useful in metabolic homeostasis research .
-
Onjisaponin B
Onjisaponin B induces autophagy via the AMPK-mTOR signaling pathway, increases the NGF level and accelerates both the removal of mutant huntingtin and A53T α±-synuclein, it may have potential therapeutic effects on Parkinson disease, Alzheimer disease and Huntington disease.
-
HTH-01-015
HTH-01-015 is a potent, specific NUAK1 (AMPK-related kinase 5, ARK5) inhibitor with IC50 of 100 nM.
